Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Opisthopappus longilobus

ABSTRACT: Opisthopappus longilobus Genome sequencing and assembly

PROVIDER: PRJNA868507 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21041000_1.fastq.gz	Fastqsanger.gz
	SRR21041000_2.fastq.gz	Fastqsanger.gz
	SRR21041001_1.fastq.gz	Fastqsanger.gz
	SRR21041001_2.fastq.gz	Fastqsanger.gz
	SRR21041002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Opisthopappus taihangensis

Project description:Opisthopappus taihangensis overview

| PRJNA526273 | ENA

Opisthopappus longilobus

Project description:Opisthopappus longilobus overview

| PRJNA883495 | ENA

Opisthopappus taihangensis

Project description:Opisthopappus taihangensis 'Taihang Mingzhu'

| PRJNA868887 | ENA

Opisthopappus taihangensis

Project description:Opisthopappus taihangensis Raw sequence reads

| PRJNA526138 | ENA

Opisthopappus taihangensis

Project description:Opisthopappus taihangensis Raw sequence reads

| PRJNA400848 | ENA

Opisthopappus taihangensis

Project description:Transcriptome of Opisthopappus taihangensis's root

| PRJNA437359 | ENA

Opisthopappus taihangensis cultivar:O. taihangensis

Project description:Opisthopappus taihangensis cultivar:O. taihangensis Genome sequencing and assembly

| PRJNA868878 | ENA

Opisthopappus taihangensis

Project description:Opisthopappus taihangensis Raw sequence reads of small RNA in respnse to drought

| PRJNA507293 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Transcriptome of Opisthopappus

| PRJNA471103 | ENA